OmicScouts integrates quantitative mass spectrometry-based proteomics and bioinformatics with biochemical and cell culture services to advance client's drug discovery, disease biology, and clinical research. OmicScouts' technologies enable unbiased and comprehensive identification of drug targets, drug selectivity, target engagement, mode of action analyses, and the discovery of pharmacodynamics and drug response biomarkers.